PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Digoxin is used to control ventricular response rates and improve cardiac output [PMID:32310485].
Cardiac glycosides from D. lanata showed strong cytotoxic activities at nanomolar scale against A549, HeLa, and MCF-7 cell lines, with one compound inducing G2/M phase cell cycle arrest and inhibiting vasohibin-2 (VASH2) expression [PMID:36090389].
Digoxin exhibits concentration-dependent cytotoxic activity against SK-Mel-28 and RPMI-7951 cell lines, with increased effect when combined with betulinic acid [PMID:36430989].
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 32310485 (2026) — Clinical Use of Digitalis: A State of the Art Review. · American journal of cardiovascular drugs : drugs, devices, and other interventions
- 2.PMID: 38226483 (2024) — Progesterone Metabolism in Digitalis and Other Plants-60 Years of Research and Recent Results. · Plant & cell physiology
- 3.PMID: 27731735 (2001) — Digoxin overdose: clinical features and managementVanessa Bara discusses the risk factors, antidotal therapy, and management of digoxin toxicity. · Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association
- 4.PMID: 36090389 (2022) — Cardiac glycosides from Digitalis lanata and their cytotoxic activities. · RSC advances
- 5.PMID: 36222367 (2023)